AI assistant
Novonesis AS — Major Shareholding Notification 2012
May 7, 2012
3377_mrq_2012-05-07_4bb21cdb-628a-47f1-a992-2a7895f4a6d1.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
May 4, 2012
In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co (through holdings in Baillie Gifford & Co, and through its wholly owned subsidiary, Baillie Gifford Overseas Limited) has increased its holding of B shares in Novozymes A/S to a total of 25,388,300 B shares of a nominal value of DKK 50,776,600, equivalent to 7.81% of Novozymes A/S' share capital and 3.14% of the voting rights.
Contact persons:
René Tronborg (Europe) Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274
Paige Donnelly (USA) Tel. (direct): +1 919 494 3209 Tel. (mobile): +1 919 218 4501
Press and media: Investor relations:
Martin Riise Tel. (direct): +45 4446 0738 Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA) Tel. (direct): +1 919 494 3483 Tel. (mobile): +1 919 649 2565
Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.
Krogshoejvej 36 2880 Bagsvaerd Denmark
Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27